News
Home > News > News
- 2024/09/12The company accomplished Methocarbamol remote audit.
- 2024/08/29CCSB accomplished Rapamycin audit.
- 2024/05/17CCSB accomplished Mycophenolate Mofetil audit.
- 2024/04/30CCSB accomplished Ethyl Icosapentate, Everolimus, etc. audit
- 2024/04/26CCSB accomplished Methocarbamol audit.
- 2024/04/12CCSB accomplished an inspection of The Food and Drug Administration (USFDA).
- 2024/04/10CCSB accomplished an inspection of Münster, Germany.
- 2024/01/25CCSB accomplished Caspofungin audit.
- 2024/01/11CCSB obtained US patent for Tofacitinib Citrate
- 2023/01/17CCSB obtained US patent for Etelcalcetide
